Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination
- PMID: 35496775
- PMCID: PMC9034829
- DOI: 10.1016/j.bbih.2022.100463
Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination
Abstract
Vaccination is an essential public health strategy to control the 2019 Coronavirus (COVID-19) pandemic. While the benefits of the COVID-19 vaccines far outweigh the risks, side effects continue to be reported in the literature. We report a 65-year-old man who developed cognitive deficits and memory impairments following his first dose of Oxford AstraZeneca vaccine (Covishield). The onset of acute cognitive deficits and memory impairments could be another complication to COVID-19 vaccination that physicians and neurologists need to be warned to. Monitoring the safety of COVID-19 vaccines and describing side effects associated with them is essential to improve safety profiles and enhance public trust.
Keywords: COVID-19; Cognitive deficits; Coronavirus; SARS-CoV; Vaccination.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Blauenfeldt R.A., Kristensen S.R., Ernstsen S.L., Kristensen C.C.H., Simonsen C.Z., Hvas A.M. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J. Thromb. Haemostasis. 2021;19(7):1771–1775. doi: 10.1111/jth.15347. - DOI - PMC - PubMed
-
- Di Carlo D.T., Montemurro N., Petrella G., Siciliano G., Ceravolo R., Perrini P. Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature. J. Neurol. 2021;268(5):1561–1569. doi: 10.1007/s00415-020-09978-y. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
